40: A Shot at Love with Nonprofit Insulin

Nonprofit pharmaceutical company Civica has released it's biosimilar version of Lantus long-acting insulin for $55 for a box of 5 pens—that's the list price it costs you to buy it without needing insurance, coupons, or patient assistance programs. We look at how a nonprofit business model can drastically lower prices for patients and governments.

Things we talk about:https://betacellaction.org/119th-congress

• More info about Civica insulin and CalRx Insulin
• CalRx Patient Advisory Council Charter
• Episode on insulin pricing
• Episode on co-pay cap laws
• 119th Congress pro-healthcare scorecard

Support Beta Cell on Patreon.